St. Jude Cloud

Apr 12, 2018

St. Jude Children's Research Hospital, in partnership with DNANexus and Microsoft, has introduced St. Jude Cloud, a public repository of genomics data on pediatric cancer. The St. Jude Cloud platform, which includes free analytics and visualization tools, contains more than 5,000 anonymized whole-genome sequences and 1,200 RNA sequences from young cancer patients. Researchers also are able to upload their own data for analysis and visualization on the cloud-based platform.

More Like This

Aug 13, 2018

Empirical Bioscience EB Pure Agarose Gel Extraction Kit

Empirical Bioscience has introduced the EB Pure Agarose Gel Extraction Kit, which is designed to isolate small DNA fragments (70 bp to 20 kb) from agarose gel in 15 minutes. The system specifically but reversibly binds DNA or RNA under optimized conditions allowing proteins and other contaminants to be removed. This helps to guarantee consistent recovery rates in excess of 85 percent while simultaneously removing primer-dimers, primers, nucleotides, proteins, salt, agarose, ethidium bromide, and other impurities. The extracted DNA is suitable for use in most applications including ligations, PCR, sequencing, restriction digestion, or various labeling reactions, Empirical said.

Aug 10, 2018

Helomics Precision Oncology Insights Program

Helomics announced that it has launched its new Precision Oncology Insights platform, which provides a personalized oncology roadmap for oncologists and their patients. Having been acquired by Precision Therapeutics in June, Helomics will offer the platform as a tool to test living tumor tissue from the patient to detemrine how the tumors respond to drugs. Helomics then integrates the drug response with other genomic and molecular data. The firm's artificial intelligence knowledge base, Dynamic Clinical Health Insights platform, then analyzes the data to generate a roadmap that provides additonal context to help personalize patient treatment.

Aug 07, 2018

Oxford Gene Technology SureSeq Interpret

Oxford Gene Technology has launched its SureSeq Interpret software for next-generation sequencing data analysis. The software was designed for use with the SureSeq NGS panels and is included with the purchase of the panels. For calling mutations with a greater than 1 percent variant allele frequency, the software has 100 percent sensitivity and 99.9 percent specificity. It can call SNVs, indels, and structural variants.

Aug 03, 2018

Enpicom ImmunoGenomix Platform

Dutch bioinformatics software engineering company Enpicom has released the first version of its ImmunoGenomix platform to support the development of immunotherapies, as well as patient stratification and treatment monitoring. The firm will expand the platform into a comprehensive immunosequencing data analysis platform designed to analyze, monitor, and compare the immune repertoires in the context of immunotherapy development and at all stages of treatment and disease over time. The platform will enable customers to use their own sample preparation protocols and preferred next-generation sequencing technology.

Aug 03, 2018

BD AbSeq Assay

Becton Dickinson has announced the commercial release of its BD AbSeq assay, which will analyze protein expression at the single-cell level using high-throughput sequencing. The assay integrates high-quality antibodies from the BD Pharmingen portfolio with oligonucleotides, allowing researchers to perform single-cell analysis on the firm's Rhapsody single-cell analysis system. When used in tandem, the tools allow researchers to simultaneously analyze RNA and proteins in thousands of individual cells and develop a clearer picture of the role genes and proteins play in biological systems. 

Jul 26, 2018

MedTek21 Version 4.0

MedTek21 has introduced version 4.0 of its eponymous medication management platform for precision medicine, which includes drug-to-gene monitoring. The new release adds reporting for patients at risk for harmful pharmacogenomic interactions as well as real-time alerts either through electronic health records systems or a standalone application. MedTek21 version 4.0 also features two-way integration with Epic Systems and Cerner EHRs and several popular pharmacy information systems. 

Jul 26, 2018

Asuragen AmplideX PCR/CE SMN1 Kit

Asuragen has announced the launch of its AmplideX PCR/CE SMN1 Kit. The kit provides a simple and scalable determination of functional SMN1 copy number within four hours. The assay is compatible with Thermo Fisher Scientific Applied Biosystem capillary electrophoresis instruments and leverages Asuragen's AmplideX Reporter software to automate and streamline reporting of results.

Jul 26, 2018

Biofortuna AmpDRY Air-Dried Master Mix

Biofortuna announced today that it will launch its ampDRY master mix for PCR applications at the American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo 2018. The firm has developed its ampDRY hot-start master mix to allow complete endpoint or real-time PCR assays to be stabilized in a dry format at ambient temperatures for at least 12 months. Biofortuna said that it also offers full in vitro diagnostic contract manufacturing services using ampDRY, and can customize the manufacturing process to match customer requirements and develop bespoke, cost-effective stabilized products. 

Jul 25, 2018

SeraCare AccuSpan HCV RNA Linearity Panel

SeraCare has expanded its AccuPlex line with the launch of the AccuSpan HCV RNA Linearity Panel. The eight-member panel has been qualified against World Health Organization standards and is made from serial dilutions of high-titer recombinant hepatitis C virus, genotype 1b, with established reactivity for HCV RNA, and one negative control. The panel can be used by researchers, diagnostics manufacturers, and clinical labs to develop, evaluate, and validate HCV molecular test methods. The panel is useful for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, assessing lot-to-lot variability of kits, performing linearity studies, or any time there may be deterioration in diagnostic assays, according to the firm. It uses SeraCare's proprietary AccuPlex technology, which packages recombinant viral material in a way that is stable, replication-deficient, non-infectious, and mimics a real patient sample throughout the diagnostic workflow.

Jul 24, 2018

Microbiologics Molecular Diagnostics QC Panels

Microbiologics has launched new panels for the verification and routine quality control of common molecular assays. They include four panels for women's health and sexually transmitted infection testing: a human papillomavirus control panel; human papillomavirus verifcation panel; vaginal control panel; and vaginal verification panel. The company also launched new panels for blood culture identification and gastrointestinal testing: a blood culture control panel; blood culture verification panel; enteric viral control panel; and enteric viral verification panel. The new panels are designed to mimic patient sample processing, Microbiologics said. 

Jul 20, 2018

Sage Bionetworks Agora Platform

Sage Bionetworks has launched the Agora platform, a web-based tool that allows researchers to explore curated genomic analyses of Alzheimer's disease. The analyses resulted from the Accelerating Medicines Partnership – Alzheimer's Disease (AMP-AD) Target Discovery and Preclinical Validation Project, a public-private partnership led by the National Institute on Aging and managed by the Foundation for the NIH (FNIH). Through the Agora portal, which will be frequently updated, the analyses are now available to researchers outside the AMP-AD consortium. The initial release includes differential expression and co-expression network meta-analyses across four human RNA sequence data sets. Future releases will include human proteomic and metabolomic analyses, comparative evaluations of disease signatures across species, and druggability and tractability information to guide the selection of targets for early drug discovery.

Jul 19, 2018

Swift Biosciences 2S Turbo Library Kit

Swift Biosciences is now offering early access to its Swift 2S Turbo Library Kit. The kit enables researchers to complete library prep workflow in two hours with as low as 1 ng of input. Researchers can use a range of sample types, including fresh and fresh-frozen tissue, human or microbial genomic DNA, formalin-fixed paraffin-embedded samples, and PCR amplicons.

Jul 18, 2018

MNG Laboratories Comprehensive Intellectual Disability/Autism Panel

MNG Laboratories has added mitochondrial DNA sequencing and deletion analysis to its Comprehensive Intellectual Disability/Autism next-generation sequencing panel at no additional cost.

Jul 17, 2018

AMS Biotechnology CRISPR Complete Kits

AMS Biotechnology has released CRISPR-Cas9 editing kits for gene knockout, gene knock-in, and gene mutation applications. Developed by the firm's genetic engineers, the AMSBIO CRISPR Complete kits are made for specific projects including knockouts, knock-ins, point mutations, gene replacements, humanizations, tagging, and more. 

Custom-designed CRISPR Complete kits include tracrRNA and Cas9 nuclease, as well as crRNA and donor constructs that are also custom-designed for the project. The firm can offer the donor construct as an oligonucleotide or plasmid, depending on the project's needs.

Jul 17, 2018

Biocartis Idylla MSI Assay

Biocartis announced today that it has launched its automated Idylla MSI assay. The research-use-only assay provides information on the microsatellite instability-status of a tumor in about 150 minutes from one slice of FFPE tumor tissue without requiring a reference sample. The assay includes a set of seven MSI biomarkers, including ACVR2A, BTBD7, DID01, MRE11, RYR3, SEC31A, and SULF2 genes. 

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.